Menu

The facts on 1,4-Dioxane

Table of contents

The facts on 1,4-Dioxane

Last update September 3, 2024

It is estimated that up to 30,000 workers are exposed to 1,4-dioxane in the EU. Typical workplaces, where 1,4-dioxane is used, are in the rubber and chemical industry. It can also occur as a by-product in the cosmetics industry. Workers are mainly exposed through airborne contamination and by dermal contact, although oral exposure is possible as well. 1,4-dioxane is classified as category 1B carcinogen according to CLP legislation (Carc. 1B) and is suspected to contribute to carcinomas in the nose as well as tumors in the liver and kidneys. In addition, 1,4-dioxane causes severe eye irritation and may cause respiratory irritation; repeated exposure to the skin may cause dryness or cracking.

Where risk occur

Occupational exposure occurs during the production, processing, and use of 1,4-dioxane, via inhalation or dermal exposure. 1,4-Dioxan is often used as a solvent, in laboratories (e.g., mobile phase in chromatography) and at industrial sites in polymerisation processes. Cleaning and maintenance activities are also important to consider regarding exposure.

More about the substance

1,4-dioxane is a clear, colourless liquid, readily mixed with other solvents. Because of its inertness it is mainly used as solvent itself. It is highly flammable and may form explosive peroxides. 1,4-dioxane is an anthropogenic chemical that does not occur naturally in the environment. It is a known by-product of industrial ethoxylation processes and can thus bepresent as contaminant in cosmetics and personal care products, where its concentration is strictly regulated. 1,4-Dioxane has also been found as residue in articles of plastic and rubber (e.g., gloves, boots, clothing, rubber handles, gear lever, steering wheels).

1,4-dioxane is stable in water and does not break down. Compounds in the air can break down 1,4-dioxane into different compounds rapidly. There is contamination in the environment (groundwater) related to the disposal of chemical solvents containing 1,4-dioxane and from disposal of 1,4-dioxane itself.

How symptoms can affect you

1,4-Dioxane is rapidly and almost completely absorbed after inhalation and oral exposure. The absorption via skin is also relevant. After inhaling 1,4-dioxane, upper abdominal pain and vomiting, as well as irritation of the eyes and respiratory tract may occur. Other symptoms of 1,4-dioxane intoxication include liver and kidney damage, convulsions and coma. In this context, a simultaneous dermal absorption of the substance should be taken into account. Besides, repeated dermal exposure to 1,4-dioxane can lead to skin damage.
Additionally, in animal studies effects on the liver and kidneys as well as on the central nervous system like staggered gait, narcosis, paralysis and coma were observed. It should be noted, that the main target organs are the respiratory system, liver and kidneys after long-term exposure.

What you can do

Substitution should be considered in applications where feasible. If alternatives are not available or 1,4-dioxane might occur as by-product, perform proper exposure measurements periodically so it is known when and where actions should be taken. To avoid adverse health effects it is, therefore, of utmost importance to reduce exposure below the health-based limit value. In industrial processes, examples of technical control measures are enclosed systems, general exhaust and local exhaust ventilation. Even when working with closed systems, exposure can occur e. g. during sampling tasks. Measurements and control measures are of relevance there. Other recommended work practices include providing employees with hazard information and training, and general working hygiene standards for chemical handling areas. Workers in maintenance and cleaning should be trained as well. Investigate if workers report early symptoms. It is recommended to involve an occupational physician. Be aware that for 1,4-dioxane the exposure assessment can be supported with biomonitoring, if applicable under national legislation. Workers need to be aware of the effects of exposure. Personal protective equipment should only be used as a last resort, after introducing the possible engineering solutions.

Sources: BAuA, CLP, German MAK-commission, RAC

Limit values

EU
Values to be determined (national limits might apply).
 Austria
73mg/m³ (TWA)
146mg/m³ Short term
 Belgium
73 mg/m3 (TWA)
Bulgaria
EU directive
Croatia
EU directive
Czech Republic
EU directive
Cyprus
EU directive
Denmark
36mg/m³ (TWA)
72mg/m³ Short term
Estonia
EU directive
Finland
36mg/m³ (TWA)
140mg/m³ short term
France
73mg/m³ (TWA)
Germany
73mg/m³ (TWA)
146mg/m³ Short term
Greece
EU directive
Hungary
73mg/m³ (TWA)
Iceland
EU directive
Ireland
73mg/m³ (TWA)
Italy
73mg/m³ (TWA)
Latvia
20mg/m³
Lithuania
EU directive
Luxembourg
EU directive
Malta
EU directive
Netherlands
TWA 8h: 20 mg/m3 (5.5 ppm)
North Macedonia
EU directive
Norway
18mg/m³ (TWA)
36mg/m³ short term
Poland
50mg/m³
Portugal
EU directive
Romania
73mg/m³ (TWA)
Serbia
EU directive
Slovakia
EU directive
Slovania
EU directive
Spain
VLA-ED= 20 ppm (73 mg/m3)
Sweden
35mg/m³ (TWA)
90mg/m³ short term
Turkey
73mg/m³

References: cancer.gov, EFSA, IARC, EC, NIOSH, OSHA, CAREX

Possible substitutions

ECHA registration
CAS number 123-91-1
EC number 204-661-8
Annex VI of CLP 1B
Number of registrations (2023) 8
Tonnage band registred (2023) ≥ 1 000 to < 10 000 tonnes per annum

The European Chemicals Agency (ECHA) works for the safe use of chemicals. It implements the EU’s groundbreaking chemicals legislation, benefiting human health, the environment and innovation and competitiveness in Europe.

GESTIS Database

The data pool may be used for the purpose of occupational health and safety or to obtain information on the hazards posed by chemical substances.

General facts

Facts about cancer-causing agents:

  • The direct costs of carcinogen exposure at work across Europe are estimated at 2.4 billion Euros per year.
  • Every year, about 120.000 persons get cancer from exposure to carcinogens at work
  • Every year, almost 100.000 people die from cancer that was caused by exposure at work
  • Annually more than 100.000 people die because of work-related cancer.
Table of contents